NEW YORK (GenomeWeb News) – Bruker BioSciences announced today that it will acquire its privately held Bruker BioSpin affiliate for $914 million in cash and stock.
 
Bruker BioSpin develops and manufactures life science and analytical research instruments based on its magnetic resonance core technology. The firm is 100 percent-owned by members of the Laukien family, who also own 52 percent of publicly traded Bruker BioSciences.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.